6
1
Cat. No. | Product Name | ||
---|---|---|---|
L2130 | 抗癌细胞代谢库 | 1268 compounds | |
1268 种癌细胞代谢相关的生物活性小分子化合物的特有集合,用于肿瘤相关的研究以及抗肿瘤药物的筛选,用于高通量、高内涵筛选; |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1315 |
c-Myc Peptide Trifluoroacetate
|
Others | Others |
c-Myc Peptide Trifluoroacetate (145646-22-6 free base) 是一种合成肽,对应于人类 c-myc 蛋白的 C 末端氨基酸 (410-419),参与调控生长相关基因的转录。 | |||
TP2311 |
C-MYC PEPTIDE EPITOPE TFA
|
Others | Others |
C-MYC PEPTIDE EPITOPE TFA 是 c-myc 原癌基因的产物,是一种螺旋-环-螺旋亮氨酸拉链磷蛋白,可调节细胞增殖、细胞分化和凋亡中的基因转录。该肽是人类 c-myc 表位。 | |||
T8838 |
CCI-007
|
Apoptosis; Histone Methyltransferase | Apoptosis; Chromatin/Epigenetic |
CCI 007 是一种具有细胞毒性的选择性白血病抑制剂,在MLL 重排的敏感系婴幼儿白血病细胞中,IC50为2.5-6.2 μM。 | |||
TP2179 |
c-Myc tag Peptide
|
Others | Others |
c-Myc Peptide is a useful displacement of c-Myc-tagged fusion proteins bound to anti-c-Myc antibodies in immunoassays. The successful inhibition of antibody binding by c-Myc peptide demonstrates binding is specific. c-Myc peptide participates in the regul | |||
T69771 |
MS-177
|
PROTACs | PROTAC |
MS177 is an effective and fast-acting EZH2 degrader. MS177 is a PROTAC that consists of a CRBN ligand, linker, and a potent enzymatic EZH2 inhibitor C24 (C24 IC50): 12 nM). MS177 effectively depletes both canonical EZH2–PRC2 and noncanonical EZH2–cMyc complexes. MS177 induces leukaemia cell growth inhibition, apoptosis and cell cycle progression arrest. | |||
T83936 |
LL-K9-3
|
Others | Others |
LL-K9-3是一种基于选择性疏水标记技术(HyT)的CDK9-cyclin T1复合物降解剂(DC50值分别为cyclin T1的589 nM和CDK9的662 nM)。它由CDK9抑制剂SNS 032和一个糖基连接器连接到疏水标记组成。LL-K9-3不会降解其他CDKs(CDK1、2、4、5、6和7)。在22RV1细胞中,LL-K9-3通过诱导CDK9和cyclin T1的选择性和同步降解,降低雄激素受体(AR)和cMyc的表达。 |